Enzyme linked immunosorbent assay for the quantification of nivolumab and pembrolizumab in human serum and cerebrospinal fluid by Pluim, Dick, Ros, Willeke, van Bussel, Mark T.J., Brandsma, Dieta, Beijnen, Jos H., Schellens, Jan H.M.

Get full text

Liquid chromatography–tandem mass spectrometric assay for the T790M mutant EGFR inhibitor osimertinib (AZD9291) in human plasma by Rood, Johannes J.M., van Bussel, Mark T.J., Schellens, Jan H.M., Beijnen, Jos H., Sparidans, Rolf W.

Get full text

A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours by van Bussel, Mark T. J., Awada, Ahmad, de Jonge, Maja J. A., Mau-Sørensen, Morten, Nielsen, Dorte, Schöffski, Patrick, Verheul, Henk M. W., Sarholz, Barbara, Berghoff, Karin, El Bawab, Samer, Kuipers, Mirjam, Damstrup, Lars, Diaz-Padilla, Ivan, Schellens, Jan H. M.

Get full text

Intracranial antitumor responses of nivolumab and ipilimumab: a pharmacodynamic and pharmacokinetic perspective, a scoping systematic review by van Bussel, Mark T J, Beijnen, Jos H, Brandsma, Dieta

Get full text

EpCAM-based assays for epithelial tumor cell detection in cerebrospinal fluid by van Bussel, Mark T. J., Pluim, Dick, Bol, Mijke, Beijnen, Jos H., Schellens, Jan H. M., Brandsma, Dieta

Get full text

Reported hepatotoxicity and hepatotoxicity guidance in the product information of protein kinase inhibitors in oncology registered at the European Medicines Agency by Maliepaard, Marc, Faber, Yoran S., Bussel, Mark T. J.

Get full text

A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With [BRAF.sup.V600E]-Mutant KRAS Wild- Type Metastatic Colorectal Cancer by Tabernero, Josep, Van Cutsem, Eric, Garralda, Elena, Tai, David, De Braud, Filippo, Geva, Ravit, van Bussel, Mark T.J, Dotti, Katia Fiorella, Elez, Elena, de Miguel, Maria J, Litwiler, Kevin, Murphy, Danielle, Edwards, Michelle, Morris, Van Karlyle

Get full text

Representation of older patients in the safety analysis of protein kinase inhibitor registration studies by van Kampen, Emma, van Bussel, Mark T.J., Oude Munnink, Thijs H., Touw, Daan J., Broekman, K. Esther

Get full text

Designing Dose-Optimization Studies in Cancer Drug Development: Discussions with Regulators by Marchenko, Olga, Sridhara, Rajeshwari, Jiang, Qi, Barksdale, Elizabeth, Ando, Yuki, Alwis, Dinesh De, Brown, Katie, Fernandes, Laura, van Bussel, Mark T. J., Choo, Qiuyi, Coory, Michael, Garrett-Mayer, Elizabeth, Gwise, Thomas, Hess, Lorenzo, Liu, Rong, Mandrekar, Sumithra, Ouellet, Daniele, Pinheiro, José, Posch, Martin, Rahman, Nam Atiqur, Rantell, Khadija Rerhou, Raven, Andrew, Sarem, Sarem, Sen, Suman, Shah, Mirat, Shen, Yuan Li, Simon, Richard, Theoret, Marc, Yuan, Ying, Pazdur, Richard

Get full text